Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
47M
-
Shares change
-
+1.37M
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
+$37.7M
-
Put/Call ratio
-
1.68
-
Number of buys
-
111
-
Number of sells
-
-104
-
Price
-
$33.53
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2020
264 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q1 2020.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
.
Largest 10 shareholders include BlackRock Inc. (6.82M shares), VANGUARD GROUP INC (4.37M shares), RENAISSANCE TECHNOLOGIES LLC (2.47M shares), PAULSON & CO. INC. (1.72M shares), MACQUARIE GROUP LTD (1.71M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.63M shares), BAILLIE GIFFORD & CO (1.41M shares), STATE STREET CORP (1.4M shares), Stephens Investment Management Group LLC (1.24M shares), and Spyglass Capital Management LLC (1.19M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.